Evidence map›Paper›PMID 24356209›Full record

ArticleJournal of medical ethics2014

Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases.

Erika Kleiderman, Bartha Maria Knoppers, Conrad V Fernandez, Kym M Boycott, Gail Ouellette, Durhane Wong-Rieger, Shelin Adam, Julie Richer, Denise Avard

Abstract read
In one paragraph

Article in Journal of medical ethics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Participant choices for return of genomic results in the eMERGE Network.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erika KleidermanCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
Bartha Maria KnoppersCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
Conrad V FernandezCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
Kym M BoycottFaculty of Medicine, Departments of Pediatrics and Bioethics, Dalhousie University, Halifax, Nova Scotia, Canada.
Gail OuelletteChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ontario, Canada.
Durhane Wong-RiegerRegroupement Québécois des Maladies Orphelines, Sherbrooke, Quebec, Canada.
Shelin AdamInstitute for Optimizing Health Outcomes, Canadian Organization for Rare Disorders, Toronto, Ontario, Canada.
Julie RicherDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Denise AvardCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

purposeTo explore parental perceptions and experiences regarding the return of genomic incidental research findings in children with rare diseases.

methodsParents of children affected by various rare diseases were invited to participate in focus groups or individual telephone interviews in Montreal and Ottawa. Fifteen participants were interviewed and transcriptions were analysed using thematic analysis.

resultsFour emergent themes underscored parental enthusiasm for receiving incidental findings concerning their child's health: (1) right to information; (2) perceived benefits and risks; (3) communication practicalities: who, when, and how; and (4) service needs to promote the communication of incidental findings. Parents believed they should be made aware of all results pertaining to their child's health status, and that they are responsible for transmitting this information to their child, irrespective of disease severity. Despite potential negative consequences, respondents generally perceived a favourable risk-benefit ratio in receiving all incidental findings.

conclusionsUnderstanding how parents assess the risks and benefits of returning incidental findings is essential to genomic research applications in paediatric medicine. The authors believe the study findings will contribute to establishing future best practices, although further research is needed to evaluate the impact of parental decisions on themselves and their child.

Indexed as

Incidental FindingsAdolescentAdultChildChild, PreschoolFemaleGenetic ResearchHumansMaleMiddle AgedParentsPediatricsRare DiseasesYoung Adult

Identifiers

PMID24356209
PMCPMC4173986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.